Clinical trials: Anesthesia, Intravenous
- Condition Anesthesia, Intravenous
- Funder type Industry (pharma, biotech, devices)
- Age group Children (under 18)
Anesthesia
Protocol for Eslax Intravenous Drug Use Investigation (Study P06082)
The main purpose of this investigation is to collect safety and efficacy information of Eslax Intravenous 25mg/2.5mL and 50mg/5.0mL (hereinafter referred to as "Eslax") in daily clinical settings.
- Trial name
- NCT00902070
- Testing
- Rocuronium
- Volunteers
- 3,969 people
- Sponsor
- Merck Sharp & Dohme LLC